# Alkali Therapy in Chronic Kidney Disease

Study · id `cardio:ct-nct01452412` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01452412](<https://clinicaltrials.gov/study/NCT01452412>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01452412

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 149 participants.

## Technical summary

Registry record NCT01452412. Randomized; quadruple masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2016-08 (actual). Results posted on 2020-01-07.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 149 participants (enrolled count; ClinicalTrials.gov record NCT01452412, source copy `cardio:ctgov-nct01452412-2020-01-07`, retrieved 2026-10-26)
- Start date: 2011-10 (registry gives no type) (ClinicalTrials.gov record NCT01452412, source copy `cardio:ctgov-nct01452412-2020-01-07`, retrieved 2026-10-26)
- Primary completion: 2016-08 (actual) (ClinicalTrials.gov record NCT01452412, source copy `cardio:ctgov-nct01452412-2020-01-07`, retrieved 2026-10-26)
- Completion: 2016-08 (actual) (ClinicalTrials.gov record NCT01452412, source copy `cardio:ctgov-nct01452412-2020-01-07`, retrieved 2026-10-26)
- Results first posted: 2020-01-07 (ClinicalTrials.gov record NCT01452412, source copy `cardio:ctgov-nct01452412-2020-01-07`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01452412, source copy `cardio:ctgov-nct01452412-2020-01-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01452412-2020-01-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Alkali Therapy in Chronic Kidney Disease
- Condition: Chronic Kidney Disease
- Condition: Metabolic Acidosis
- Intervention (Drug): Sodium bicarbonate
- Intervention (Drug): Placebo
- Lead sponsor: Albert Einstein College of Medicine
- Lead sponsor class: OTHER
- Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Collaborator class: NIH
- Collaborator: National Institutes of Health (NIH)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Albert Einstein College of Medicine (`cardio:org-albert-einstein-college-of-medicine`)
- Registry lists this organization as a collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (`cardio:niddk`)
- Registry lists this organization as a collaborator: National Institutes of Health (`cardio:nih`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of Sodium Bicarbonate in CKD Stages 3 and 4: A Randomized, Placebo-Controlled, Multicenter Clinical Trial (`cardio:pubmed-31699517`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 9fc203269163420bec57d90e27eefee0583c27b6a3b61e4277e320eec0b49b4b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
